⌘K
Loading ticker…
Nuvation Bio Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Nuvation Bio Inc. (NUVB) has a 3-month relative strength percentile of 79 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 68. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.1%, relative volume 6.01×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 79, Market Stance is mixed at 47, A/D rating D
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
NUVB is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $37M notional. Top 3 carry $74M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $37M |
| IWMiShares Russell 2000 ETF | 0.04% | $25M |
| VXFVanguard Extended Market ETF | 0.01% | $11M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.79% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $712K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NUVB Jan avg: -4.82% median: -2.94% win: 50% σ: 29.71% n: 4 2022-04-12 → 2026-05-29 | NUVB Feb avg: -1.91% median: -0.97% win: 50% σ: 18.71% n: 4 2022-04-12 → 2026-05-29 | NUVB Mar avg: 10.54% median: -12.55% win: 25% σ: 56.53% n: 4 2022-04-12 → 2026-05-29 | NUVB Apr avg: -0.47% median: -3.01% win: 40% σ: 17.93% n: 5 2022-04-12 → 2026-05-29 | NUVB May avg: -3.66% median: 0.62% win: 60% σ: 12.48% n: 5 2022-04-12 → 2026-05-29 | NUVB Jun avg: -2.73% median: -6.91% win: 25% σ: 9.29% n: 4 2022-04-12 → 2026-05-29 (current) | NUVB Jul avg: 10.04% median: 11.90% win: 75% σ: 20.31% n: 4 2022-04-12 → 2026-05-29 | NUVB Aug avg: 0.01% median: -4.95% win: 50% σ: 18.73% n: 4 2022-04-12 → 2026-05-29 | NUVB Sep avg: -10.65% median: -19.15% win: 25% σ: 23.94% n: 4 2022-04-12 → 2026-05-29 | NUVB Oct avg: 1.93% median: -2.64% win: 25% σ: 28.74% n: 4 2022-04-12 → 2026-05-29 | NUVB Nov avg: 25.14% median: 29.95% win: 75% σ: 27.94% n: 4 2022-04-12 → 2026-05-29 | NUVB Dec avg: 6.40% median: 6.05% win: 75% σ: 13.08% n: 4 2022-04-12 → 2026-05-29 |